We have previously shown that low dose transdermal estrogen pre-treatment selectively reduced inflammatory cytokines in women with obesity accompanied by an increase in LH pulse amplitude and GnRH stimulated FSH [4]. This evidence concerns the gene GNRH1 and obesity disorder.